Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1998 2
1999 2
2000 1
2001 5
2003 3
2004 6
2005 5
2006 5
2007 10
2008 7
2009 4
2010 8
2011 5
2012 3
2013 6
2014 5
2015 5
2016 3
2017 1
2018 5
2019 5
2020 4
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 15956528

90 results
Results by year
Filters applied: . Clear all
Page 1
Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
Robinson WH, Genovese MC, Moreland LW. Robinson WH, et al. Arthritis Rheum. 2001 Sep;44(9):1977-83. doi: 10.1002/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6. Arthritis Rheum. 2001. PMID: 11592357 Free article. Review. No abstract available.
Adalimumab-associated multiple sclerosis.
Bensouda-Grimaldi L, Mulleman D, Valat JP, Autret-Leca E. Bensouda-Grimaldi L, et al. J Rheumatol. 2007 Jan;34(1):239-40; discussion 240. J Rheumatol. 2007. PMID: 17216704 No abstract available.
Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications.
Bitoun S, Miceli-Richard C, Verstuyft C, Juge PA, Dieudé P, Berthelot JM, Richez C, Cauquil C, Sordet C, Melac-Ducamp S, Gossec L, Bouvard B, Dernis E, Houvenagel E, Boutry-Bacle MA, Mariette X, Seror R. Bitoun S, et al. Ann Rheum Dis. 2018 Dec;77(12):1835-1836. doi: 10.1136/annrheumdis-2018-213183. Epub 2018 Jul 20. Ann Rheum Dis. 2018. PMID: 30030263 No abstract available.
90 results